CD63 and sarcoma: In addition, we found significantly higher values of activated platelet-derived (CD62P- and CD63-positive) microvesicles in sarcoma patients with a history of VTE, which might be a prognostic factor for the occurrence of VTE in soft tissue sarcoma patients.